Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

Abstract

THE release of cerebral acetylcholine from terminals in the cerebral cortex has been shown to be regulated by 5-hydroxytryptamine (5-HT)1–6 but it is not known which subtype of the 5-HT receptor is involved. 5-HT receptor agonists increase acetylcholine levels in vivol, 2 indicating a reduced turnover, and reduce release of acetylcholine from striatal slices in vitro3–5. Depleting 5-HT by inhibiting synthesis or by destroying the neurons containing 5-HT potentiates acetylcholine release5, and increases acetylcholine turnover in the cerebral cortex and hippocampus6. Selective antagonists for the 5-HT3 receptor subtypes which seem to have effects on mood and activity7–10 may exert their effect through the regulation of acetylcholine release in the cortex and limbic system. Radioligand binding studies show a high density of 5-HT3 receptors in the cholinergic-rich entorhinal cortex11, 12 and we provide evidence that a reduction in cortical cholinergic function can be effected in vitro by 5-HT3 receptors.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Euvrard, C., Javoy, F., Herbert, A. & Glowinski, J. Eur. J. Pharmac. 41, 281–289 (1977).

    Article  CAS  Google Scholar 

  2. Ladinsky, H., Consolo, S., Peri, G., Crunelli, V. & Samanin, R. in Cholinergic Mechanisms and Psychopharmacology (Ed. Jenden, D.J.) 615–627 (Plenum, New York, 1978).

    Book  Google Scholar 

  3. Gillet, G., Ammor, S. & Fillion, G. J. Neurochem. 45, 1687–1691 (1985).

    Article  CAS  Google Scholar 

  4. Jackson, D., Bruno, J. P., Stachowiak, M. K. & Zigmond, M. J. Brain Res. 457, 259–266 (1988).

    Article  CAS  Google Scholar 

  5. Vizi, E. S., Harsin, L. G. & Zsilla, G. Brain Res. 212, 89–99 (1981).

    Article  CAS  Google Scholar 

  6. Robinson, S. E. Life Sci. 32, 345–353 (1983).

    Article  CAS  Google Scholar 

  7. Costall, B., Domeney, A. M., Naylor, R. J. & Tyers, M. B. Br. J. Pharmac. 92, 881–894 (1987).

    Article  CAS  Google Scholar 

  8. Hagan, R. M. et al. Eur. J. Pharmac. 138, 303–305 (1987).

    Article  CAS  Google Scholar 

  9. Costall, B., Domeney, A. M., Gerrard, P. A., Kelly, M. E. & Naylor, R. J. J. Pharm. Pharmac. 40, 302–305 (1988).

    Article  CAS  Google Scholar 

  10. Jones, B. J. et al. Br. J. Pharmac. 93, 985–993 (1988).

    Article  CAS  Google Scholar 

  11. Kilpatrick, G. J., Jones, B. J. & Tyers, M. B. Nature 330, 746–748 (1987).

    Article  ADS  CAS  Google Scholar 

  12. Barnes, N. M., Costall, B. & Naylor, R. J. J. Pharm. Pharmac. 40, 548–551 (1988).

    Article  CAS  Google Scholar 

  13. Barnes, J. M., Barnes, N. M., Costall, B., Horovitz, Z. P. & Naylor, R. J. Brain Res., (in the press).

  14. Richardson, B. P., Engel, G., Donatsch, P. & Stadler, P. A. Nature 316, 126–131 (1985).

    Article  ADS  CAS  Google Scholar 

  15. Hoyer, D. T. Pharmac. Sci. 9, 89–93 (1988).

    CAS  Google Scholar 

  16. Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C. & Tyers, M. B. Br. J. Pharmac. 94, 397–412 (1988).

    Article  CAS  Google Scholar 

  17. Smith, W. W., Sancilio, L. F., Owera-Atepo, J. B., Naylor, R. J. & Lambert, L. L. J. Pharm. Pharmac. 40, 301–302 (1988).

    Article  CAS  Google Scholar 

  18. Neijt, H. C., Te Duits, I. J. & Vijverberg, H. P. M. Neuropharmac. 27, 301–307 (1988).

    Article  CAS  Google Scholar 

  19. Ireland, S. J. & Tyers, M. B. Br. J. Pharmac. 90, 229–238 (1987).

    Article  CAS  Google Scholar 

  20. Fozard, J. R. & Mobarok Ali, A. T. M. Eur. J. Pharmac. 49, 109–112 (1978).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Barnes, J., Barnes, N., Costall, B. et al. 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature 338, 762–763 (1989). https://doi.org/10.1038/338762a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/338762a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing